DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
RABIES IMMUNE GLOBULIN
4
Unknown
Approved
Unknown
Unknown
Infections; Rhabdoviridae Infections
Unknown
RABIES IMMUNE GLOBULIN
×
Maximum Phase:
4
First Approval:
None
UNII:
95F619ATQ2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IRON DEXTRAN
4
Unknown
Approved
OTHER
INJECTION
Pregnancy; Anemia; Anemia, Iron-Deficiency; Folic Acid Deficiency
Supplement
IRON DEXTRAN
×
Maximum Phase:
4
First Approval:
None
UNII:
95HR524N2M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M SULFUR COLLOID KIT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM TC-99M SULFUR COLLOID KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LYNESTRENOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
LYNESTRENOL
×
Maximum Phase:
4
First Approval:
None
UNII:
N2Z8ALG4U5
Molecule Type:
Small molecule
Molecular Formula:
C20H28O
Molecular Weight:
284.44
AlogP:
4.31
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
SODIUM NITRITE; SODIUM THIOSULFATE
4
Combination
Approved
OTHER
INTRAVENOUS
Unknown
Unknown
SODIUM NITRITE; SODIUM THIOSULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COBALTOUS CHLORIDE CO 60
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
COBALTOUS CHLORIDE CO 60
×
Maximum Phase:
4
First Approval:
None
UNII:
7812FUQ8VK
Molecule Type:
Small molecule
Molecular Formula:
Cl2Co
Molecular Weight:
130.84
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
4
Combination
Approved
OTHER
IRRIGATION
Unknown
Unknown
CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MARCAINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MARCAINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LACIDIPINE
4
Small molecule
Approved
Unknown
Unknown
Angina, Stable; Hypertension; Cardiovascular Diseases
Voltage-gated L-type calcium channel blocker
LACIDIPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
260080034N
Molecule Type:
Small molecule
Molecular Formula:
C26H33NO6
Molecular Weight:
455.55
AlogP:
4.4
PSA:
90.93
HBD:
1.0
HBA:
#RotB:
7.0
Source:
GLICLAZIDE
4
Small molecule
Approved
Unknown
Unknown
Epilepsy; Diabetes Mellitus, Type 2; Diabetes Mellitus
Sulfonylurea receptor 1, Kir6.2 blocker
GLICLAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
G4PX8C4HKV
Molecule Type:
Small molecule
Molecular Formula:
C15H21N3O3S
Molecular Weight:
323.42
AlogP:
1.63
PSA:
78.51
HBD:
2.0
HBA:
#RotB:
3.0
Source:
DOMIPHEN
4
Small molecule
Approved
Unknown
Unknown
Infections
Unknown
DOMIPHEN
×
Maximum Phase:
4
First Approval:
None
UNII:
4AZL56CU0F
Molecule Type:
Small molecule
Molecular Formula:
C22H40NO+
Molecular Weight:
334.57
AlogP:
6.06
PSA:
9.23
HBD:
0.0
HBA:
#RotB:
15.0
Source:
TOLRESTAT
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus
Aldose reductase inhibitor
TOLRESTAT
×
Maximum Phase:
4
First Approval:
None
UNII:
0T93LG5NMK
Molecule Type:
Small molecule
Molecular Formula:
C16H14F3NO3S
Molecular Weight:
357.35
AlogP:
3.56
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NORISTERAT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
NORISTERAT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODOHIPPURATE SODIUM I 131
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
IODOHIPPURATE SODIUM I 131
×
Maximum Phase:
4
First Approval:
None
UNII:
9BRV734R3E
Molecule Type:
Small molecule
Molecular Formula:
C9H7INNaO3
Molecular Weight:
331.06
AlogP:
1.11
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
3.0
Source:
INSULIN DETEMIR RECOMBINANT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INSULIN DETEMIR RECOMBINANT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN DEGLUDEC; LIRAGLUTIDE
4
Combination
Approved
Unknown
SUBCUTANEOUS
Unknown
Unknown
INSULIN DEGLUDEC; LIRAGLUTIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYALURONATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
HYALURONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
S270N0TRQY
Molecule Type:
Small molecule
Molecular Formula:
C14H23NO11
Molecular Weight:
381.33
AlogP:
-4.13
PSA:
195.24
HBD:
7.0
HBA:
#RotB:
5.0
Source:
IBALIZUMAB-UIYK
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
IBALIZUMAB-UIYK
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHAPYRILENE
4
Small molecule
Approved
Unknown
Unknown
Hypersensitivity
Unknown
METHAPYRILENE
×
Maximum Phase:
4
First Approval:
None
UNII:
A01LX40298
Molecule Type:
Small molecule
Molecular Formula:
C14H19N3S
Molecular Weight:
261.39
AlogP:
2.71
PSA:
19.37
HBD:
0.0
HBA:
#RotB:
6.0
Source:
MERISLON
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
MERISLON
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEPROTUMUMAB-TRBW
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TEPROTUMUMAB-TRBW
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARTEMISININ
4
Small molecule
Approved
Unknown
Unknown
Severe Acute Respiratory Syndrome; Schizophrenia; Malaria
Unknown
ARTEMISININ
×
Maximum Phase:
4
First Approval:
None
UNII:
9RMU91N5K2
Molecule Type:
Small molecule
Molecular Formula:
C15H22O5
Molecular Weight:
282.34
AlogP:
2.39
PSA:
53.99
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CEFTAROLINE
4
Unknown
Approved
Unknown
Unknown
Infections; Bacterial Infections; Influenza, Human; Pneumonia; Pneumonia, Bacterial; Severe Acute Respiratory Syndrome
Unknown
CEFTAROLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
C22H20N8O5S4
Molecular Weight:
604.72
AlogP:
-0.04
PSA:
179.7
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ETAFEDRINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ETAFEDRINE
×
Maximum Phase:
4
First Approval:
None
UNII:
2Y6VQU63E8
Molecule Type:
Small molecule
Molecular Formula:
C12H19NO
Molecular Weight:
193.29
AlogP:
2.06
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PIPERONYL BUTOXIDE; PYRETHRINS
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
PIPERONYL BUTOXIDE; PYRETHRINS
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN RECOMBINANT HUMAN
4
Unknown
Approved
Unknown
INJECTION
Unknown
Unknown
INSULIN RECOMBINANT HUMAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCORTISONE; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
OTIC
Unknown
Unknown
HYDROCORTISONE; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPTINEZUMAB-JJMR
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
EPTINEZUMAB-JJMR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROCATEROL
4
Small molecule
Approved
Unknown
Unknown
Asthma; Lung Diseases, Obstructive
Beta-2 adrenergic receptor agonist
PROCATEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
X7I3EMM5K0
Molecule Type:
Small molecule
Molecular Formula:
C16H22N2O3
Molecular Weight:
290.36
AlogP:
2.04
PSA:
85.35
HBD:
4.0
HBA:
#RotB:
5.0
Source:
THIMEROSAL
4
Small molecule
Approved
Unknown
Unknown
Hepatitis B, Chronic
Antimicrobial preservative, used in vaccines
THIMEROSAL
×
Maximum Phase:
4
First Approval:
None
UNII:
2225PI3MOV
Molecule Type:
Small molecule
Molecular Formula:
C9H9HgNaO2S
Molecular Weight:
404.82
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETILEFRINE
4
Small molecule
Approved
Unknown
Unknown
Ascites; Cardiovascular Diseases
Unknown
ETILEFRINE
×
Maximum Phase:
4
First Approval:
None
UNII:
ZB6F8MY53V
Molecule Type:
Small molecule
Molecular Formula:
C10H15NO2
Molecular Weight:
181.24
AlogP:
1.04
PSA:
52.49
HBD:
3.0
HBA:
#RotB:
4.0
Source:
1
2
…
302
303
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA